Eisai
4523.T
#1962
Rank
โ‚น645.30 B
Marketcap
โ‚น2,287
Share price
0.95%
Change (1 day)
-30.01%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น186.61. In 2022 the company made an earnings per share (EPS) of โ‚น136.99 a decrease over its 2021 EPS that were of โ‚น608.20.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6031.1%
2022โ‚น136.99-77.48%
2021โ‚น608.20-41.88%
2020โ‚น1,046-0.94%
2019โ‚น1,05652.59%
2018โ‚น692.26124.17%
2017โ‚น308.81-49.42%
2016โ‚น610.6037.08%
2015โ‚น445.44-11.75%
2014โ‚น504.73-3.23%
2013โ‚น521.58-18.56%
2012โ‚น640.47-15.51%
2011โ‚น758.08-3.75%
2010โ‚น787.65-1.36%
2009โ‚น798.50